Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative CapeOX Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Resectable Colon Cancer: An Open Label Randomized Controlled Phase III Trial

NCT03125980 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03125980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03125980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative CapeOX Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Resectable Colon Cancer: An Open Label Randomized Controlled Phase III Trial
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Recruiting
Start date
May 31, 2017
Completion date
May 31, 2027
Enrollment
1,370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced colon cancer